IGC insider transaction filings
IGC Pharma, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-01. Screen IGC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | GRIMALDI CLAUDIA — PFO, Director | Grant/award (A): 2,048,378 @ $0.27 | EDGAR |
| 2026-07-01 | 4 | Mukunda Ram — CEO, Director | Grant/award (A): 2,226,475 @ $0.27 | EDGAR |
| 2026-04-06 | 4 | Moran James P — Director | Option exercise (M): 80,000 @ $0 · Option exercise (M): 50,000 @ $0 · Option exercise (M): 80,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | GRIMALDI CLAUDIA — PFO, Director | Option exercise (M): 100,000 @ $0 · Option exercise (M): 138,462 @ $0.26 · Option exercise (M): 100,000 (derivative) @ $0 · Option exercise (M): 138,462 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | PRINS RICHARD K — Director | Option exercise (M): 100,000 @ $0 · Option exercise (M): 70,000 @ $0 · Option exercise (M): 100,000 (derivative) @ $0 · Option exercise (M): 70,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Mukunda Ram — CEO, Director | Option exercise (M): 333,333 @ $0 · Option exercise (M): 323,077 @ $0.26 · Option exercise (M): 16,667 @ $0 · Option exercise (M): 33,332 @ $0 · Option exercise (M): 333,333 (derivative) @ $0 · Option exercise (M): 323,077 (derivative) @ $0 · +2 more | EDGAR |
| 2026-02-04 | 4 | Mukunda Ram — CEO, Director | Option exercise (M): 50,000 @ $0 · Grant/award (A): 16,667 (derivative) @ $0 · Grant/award (A): 66,666 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | PRINS RICHARD K — Director | Option exercise (M): 100,000 @ $0 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | PRINS RICHARD K — Director | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | Moran James P — Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | LIERMAN TERRY L — Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | GRIMALDI CLAUDIA — PFO, Director | Gift (G): 50,000 @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | Mukunda Ram — CEO, Director | Gift (G): 100,000 @ $0 · Grant/award (A): 3,000,000 (derivative) @ $0 · Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — IGC Pharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-02 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | EDGAR |
| 2025-12-15 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IGC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →